Zobrazeno 1 - 10
of 259
pro vyhledávání: '"Janet B. Mcgill"'
Autor:
Samantha E. Adamson, Sangeeta Adak, Max C. Petersen, Dustin Higgins, Larry D. Spears, Rong Mei Zhang, Andrea Cedeno, Alexis McKee, Aswathi Kumar, Sudhir Singh, Fong-Fu Hsu, Janet B. McGill, Clay F. Semenkovich
Publikováno v:
Journal of Lipid Research, Vol 65, Iss 3, Pp 100519- (2024)
Metabolic syndrome affects more than one in three adults and is associated with increased risk of diabetes, cardiovascular disease, and all-cause mortality. Muscle insulin resistance is a major contributor to the development of the metabolic syndrome
Externí odkaz:
https://doaj.org/article/677128b4add74c1181e2a9749ed0e2b6
Autor:
Lauren K. Park, Kian-Huat Lim, Jonas Volkman, Mina Abdiannia, Hannah Johnston, Zack Nigogosyan, Marilyn J. Siegel, Janet B. McGill, Alexis M. McKee, Maamoun Salam, Rong M. Zhang, Da Ma, Karteek Popuri, Vincent Tze Yang Chow, Mirza Faisal Beg, William G. Hawkins, Linda R. Peterson, Joseph E. Ippolito
Publikováno v:
Cancer & Metabolism, Vol 11, Iss 1, Pp 1-12 (2023)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy. Thus, there is an urgent need for safe and effective novel therapies. PDAC’s excessive reliance on glucose metabolism for its metabolic needs provides a target for
Externí odkaz:
https://doaj.org/article/fb0695e376a84b689b17957969847ae8
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 11 (2021)
Background The frequency of the initial short‐term decline in estimated glomerular filtration rate (eGFR), eGFR dip, following initiation of sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) and its clinical implications in real‐world practi
Externí odkaz:
https://doaj.org/article/86ac9c9de9404ed59636562a770b075a
Autor:
Janet B. McGill, Mariko Johnson, Stacy Hurst, William T. Cade, Kevin E. Yarasheski, Richard E. Ostlund, Kenneth B. Schechtman, Babak Razani, Michael B. Kastan, Donald A. McClain, Lisa de las Fuentes, Victor G. Davila-Roman, Daniel S. Ory, Samuel A. Wickline, Clay F. Semenkovich
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 11, Iss 1, Pp 1-16 (2019)
Abstract Background Metabolic syndrome, an obesity-related condition associated with insulin resistance and low-grade inflammation, leads to diabetes, cardiovascular diseases, cancer, osteoarthritis, and other disorders. Optimal therapy is unknown. T
Externí odkaz:
https://doaj.org/article/883cd46428644f2bb3fe9700c5ff28bf
Autor:
Janet B. McGill
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 3 (2012)
Patients with type 2 diabetes mellitus (T2DM) frequently require multiple therapies to effectively control hyperglycemia, and many new agents for glucose control have been developed over the past few decades. Linagliptin is a recently approved oral a
Externí odkaz:
https://doaj.org/article/17173c57d17447bba9737ab77d1a8bac
Autor:
Maamoun Salam, Ryan Bailey, Peter Calhoun, Janet B. McGill, Richard M. Bergenstal, David Price, Roy W. Beck
Publikováno v:
Diabetes Technology & Therapeutics. 25:178-185
Autor:
Satish K, Garg, George, Grunberger, Ruth, Weinstock, Margaret L, Lawson, Irl B, Hirsch, Linda A, DiMeglio, Rodica, Pop-Busui, Athena, Philis-Tsimikas, Mark, Kipnes, David R, Liljenquist, Ronald L, Brazg, Yogish C, Kudva, Bruce A, Buckingham, Janet B, McGill, Anders L, Carlson, Amy B, Criego, Mark P, Christiansen, Kevin B, Kaiserman, Kurt J, Griffin, Greg P, Forlenza, Bruce W, Bode, Robert H, Slover, Ashleigh, Keiter, Chenxiao, Ling, Briggitte, Marinos, Toni L, Cordero, John, Shin, Scott W, Lee, Andrew S, Rhinehart, Robert A, Vigersky, Mary, Jane Clifton
Publikováno v:
Diabetes Technology & Therapeutics. 25:1-12
Publikováno v:
Nephrology Dialysis Transplantation. 38:542-550
BackgroundChronic kidney disease (CKD) is a complication of type 2 diabetes (T2D) with high morbidity and mortality. The prevalence of CKD in T2D is increasing due to rising numbers of persons with T2D. Multiple clinical trials have been conducted te
Autor:
Kellee M, Miller, Lauren G, Kanapka, Michael R, Rickels, Andrew J, Ahmann, Grazia, Aleppo, Lynn, Ang, Anuj, Bhargava, Bruce W, Bode, Anders, Carlson, Naomi S, Chaytor, Gail, Gannon, Robin, Goland, Irl B, Hirsch, Lisa, Kiblinger, Davida, Kruger, Yogish C, Kudva, Carol J, Levy, Janet B, McGill, Grenye, O'Malley, Anne L, Peters, Louis H, Philipson, Athena, Philis-Tsimikas, Rodica, Pop-Busui, Maamoun, Salam, Viral N, Shah, Michael J, Thompson, Francesco, Vendrame, Alandra, Verdejo, Ruth S, Weinstock, Laura, Young, Richard, Pratley
Publikováno v:
Diabetes Technol Ther
OBJECTIVE: To evaluate glycemic outcomes in the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) randomized clinical trial (RCT) participants during an observational extension phase. RESEARCH DESIGN AND METHODS: WISDM RCT was a 26-week
Publikováno v:
Diabetes, Obesity and Metabolism.